Up a level |
Li, R.K. and Tokunaga, E. and Adamchuk, H. and Vladimirov, V. and Yanez, E. and Lee, K.S. and Bondarenko, I. and Vana, A. and Hilton, F. and Ishikawa, T. and Tajima, K. and Lipatov, O. (2022) Long‑Term Safety and Efectiveness of PF‑05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2‑Positive Metastatic Breast cancer: Updated Results of a Randomized, Double‑Blind Study. BioDrugs, 36. pp. 55-69. ISSN 1173-8804 (Print) 1179-190X (Online)